PuSH - Publication Server of Helmholtz Zentrum München

Hofmeister, A.* ; Jahn-Hofmann, K.* ; Brunner, B.* ; Helms, M.W.* ; Metz-Weidmann, C.* ; Krack, A.* ; Kurz, M.* ; Li, Z.* ; Weitzenberg, M.M. ; Pflimlin, E.* ; Plettenburg, O. ; Scheidler, S.*

Syntheses of morpholine-based nucleotide analogs for hepatic siRNA targeting and stabilization.

J. Med. Chem. 64, 6838–6855 (2021)
Research data DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3'-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3'-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
7.446
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Conjugated Antisense Oligonucleotides; Solid-phase Synthesis; Asialoglycoprotein Receptor; In-vivo; High-affinity; Hepatocytes; Delivery; Subunit; Vitro; H1
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 0022-2623
e-ISSN 1520-4804
Quellenangaben Volume: 64, Issue: 10, Pages: 6838–6855 Article Number: , Supplement: ,
Publisher American Chemical Society (ACS)
Publishing Place 1155 16th St, Nw, Washington, Dc 20036 Usa
Reviewing status Peer reviewed
Institute(s) Institute of Medicinal Chemistry (IMC)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-506300-001
Scopus ID 85106494876
PubMed ID 33950677
Erfassungsdatum 2021-06-14